Literature DB >> 23537888

Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis.

Carol M Gately1, Maria Podbielska, Timothy Counihan, Michael Hennessy, Teresa Leahy, Anthony P Moran, Edward L Hogan, Joan O'Keeffe.   

Abstract

To extend our studies on glycolipid-reactive invariant Natural Killer T-cell (iNKT-cell) function in multiple sclerosis (MS), we investigated the stimulatory activities of two myelin-derived glycolipids that are poly-acetylated derivatives of β-galactosylceramide designated as fast-migrating cerebrosides (FMC) by thin-layer chromatography. In healthy subjects, FMC stimulation of peripheral blood cells significantly expanded iNKT-cells similar to α-GalCer and induced significant increases in Th1, Th2 and Th17 cytokines. In marked contrast, MS patients failed to respond to FMCs or to α-GalCer stimulation indicating an anergic response. We propose that myelin-derived FMC glycolipids stimulate iNKT-cell responses in vivo and this is blocked in MS.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23537888     DOI: 10.1016/j.jneuroim.2013.02.020

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Self-glycerophospholipids activate murine phospholipid-reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.

Authors:  Ramesh Chandra Halder; Cynthia Tran; Priti Prasad; Jing Wang; Dhiraj Nallapothula; Tatsuya Ishikawa; Meiying Wang; Dirk M Zajonc; Ram Raj Singh
Journal:  Eur J Immunol       Date:  2018-12-18       Impact factor: 5.532

Review 2.  Invariant natural killer T cells and their ligands: focus on multiple sclerosis.

Authors:  Joan O'Keeffe; Maria Podbielska; Edward L Hogan
Journal:  Immunology       Date:  2015-06-25       Impact factor: 7.397

3.  Low Memory T Cells Blood Counts and High Naïve Regulatory T Cells Percentage at Relapsing Remitting Multiple Sclerosis Diagnosis.

Authors:  João Canto-Gomes; Carolina S Silva; Rita Rb-Silva; Daniela Boleixa; Ana Martins da Silva; Rémi Cheynier; Patrício Costa; Inés González-Suárez; Margarida Correia-Neves; João J Cerqueira; Claudia Nobrega
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

Review 4.  Sphingolipid Players in Multiple Sclerosis: Their Influence on the Initiation and Course of the Disease.

Authors:  Maria Podbielska; Toshio Ariga; Anna Pokryszko-Dragan
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

Review 5.  CD1: A Singed Cat of the Three Antigen Presentation Systems.

Authors:  Radoslaw Kaczmarek; Mariola Pasciak; Katarzyna Szymczak-Kulus; Marcin Czerwinski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-04-06       Impact factor: 4.291

6.  NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.

Authors:  Josefine Ruder; Jordan Rex; Simon Obahor; María José Docampo; Antonia M S Müller; Urs Schanz; Ilijas Jelcic; Roland Martin
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

7.  Implications of Lymphocyte Anergy to Glycolipids in Multiple Sclerosis (MS): iNKT Cells May Mediate the MS Infectious Trigger.

Authors:  Edward L Hogan; Maria Podbielska; Joan O'Keeffe
Journal:  J Clin Cell Immunol       Date:  2013-06

8.  Myelin recovery in multiple sclerosis: the challenge of remyelination.

Authors:  Maria Podbielska; Naren L Banik; Ewa Kurowska; Edward L Hogan
Journal:  Brain Sci       Date:  2013-08-28

Review 9.  New Insights into Multiple Sclerosis Mechanisms: Lipids on the Track to Control Inflammation and Neurodegeneration.

Authors:  Maria Podbielska; Joan O'Keeffe; Anna Pokryszko-Dragan
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923

10.  Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients.

Authors:  Diana Ferraro; Sara De Biasi; Anna Maria Simone; Riccardo Orlandi; Milena Nasi; Francesca Vitetta; Marcello Pinti; Marco Fogliani; Stefano Meletti; Andrea Cossarizza; Patrizia Sola
Journal:  Cells       Date:  2021-11-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.